Raloxos 30mg (Raloxifene)
Raloxifene
Active ingredient: Raloxifene
Pharmacological class: selective estrogen receptor modulator (SERM)
Dosage form: tablets for oral use
Packaging: 30 mg / 50 tablets
Half-life: about 27–32 hours
Dosage: once a day
- Spedizione (se il prodotto è in stock): 3 giorni lavorativi di processing e dai 5 ai 20 giorni lavorativi di spedizione
- Spese di Processing e spedizione: 27€ in tutta Italia
Overview of Raloxifene
The raloxifene It is a selective estrogen receptor modulator (SERM) which is used both in the medical field and, in some contexts, by athletes and bodybuilders. Thanks to its selective action on tissues, raloxifene is sometimes used to counteract the negative effects of estrogen, such as gynecomastia and the water retention
Bodybuilders take raloxifene during or after anabolic steroid cycles. These compounds raise testosterone and estrogen levels, producing estrogen-dependent reactions. Raloxifene blocks estrogen activity in breast tissue while preserving beneficial effects in areas such as bone.
Medical Applications
In clinical practice, estrogen hormone therapy is often used to prevent and treat conditions related to women’s health, such asosteoporosis postmenopausal. However, the raloxifene It represents a selective alternative capable of exerting:
-
estrogenic agonist action on bone and lipid metabolism
-
antagonistic action on breast tissue and the endometrium
This tissue selectivity allows raloxifene to offer estrogen-like benefits while reducing some of the side effects typical of traditional estrogen therapy. The most common side effects include hot flashes and leg cramps, while an increased risk of thromboembolism has been documented.
Therapeutic Advantages
The main health benefits of the raloxifene include:
-
reduction in total cholesterol and LDL cholesterol
-
increase in bone mineral density
-
prevention of bone loss
These reasons led the FDA to approve raloxifene for preventing osteoporosis in women after menopause.
Comparing Raloxifene and Tamoxifen
Both raloxifene and tamoxifen belong to the SERM family and share overlap, but clear distinctions exist.
-
Mechanism of action
Tamoxifen suppresses estrogen inside breast tissue. Raloxifene acts selectively, functioning as an antagonist in certain tissues and an agonist elsewhere. -
Usage Profile
Tamoxifen is often the drug of choice in oncology, while raloxifene is more commonly used for the prevention of osteoporosis and the management of unwanted estrogenic effects. -
Cost
Tamoxifen typically costs less, though market pricing fluctuates by dosage.
Patient needs and clinical settings dictate the choice between them.
Skeletal Impact
The raloxifene It binds to estrogen receptors in bone tissue, stimulating new bone formation and slowing bone resorption. It is particularly indicated for the treatment of osteoporosis in postmenopausal women.
The Study LEARN MORE, conducted on more than 7,700 women, showed a reduction in the risk of vertebral fractures of the 30–50% compared to placebo. Further studies have shown a significant increase in bone mineral density (BMD) in the hip and spine after three years of treatment.
Cholesterol Effects
The raloxifene alters lipid profiles favorably.
-
reduction in LDL cholesterol (“bad cholesterol”)
-
increase in HDL cholesterol (“good cholesterol”)
These effects contribute to an improvement in cardiovascular risk, although they do not make raloxifene a first-line drug for the treatment of hypercholesterolemia.
Administration Guidelines
The commonly used dosage of raloxifene It generally ranges from 30 and 120 mg per day, depending on the treatment goal and the individual’s response.
Primary Actions
-
selective blocking of estrogen receptors in breast tissue
-
prevention of estrogen-induced gynecomastia
-
support for bone health and increased mineral density
-
improvement of the lipid profile
-
possible reduction in cardiovascular risk
-
potential cognitive benefits (under investigation)
Adverse Reactions
Frequent side effects from raloxifene include:
-
hot flashes
-
leg cramps
-
nausea
-
increased risk of thrombosis
-
possible increased risk of cataracts
Contraindications
Raloxifene is unsuitable for patients with:
-
history of thrombosis, stroke, or thromboembolic events
-
liver disorders or alterations in liver function
-
hypersensitivity to the active substance or to any of the excipients
Storage Rules
-
keep out of reach of children
-
store in a cool, dry place
-
protect from direct sunlight
-
store at room temperature
-
Do not use after the expiration date.
You must be logged in to post a review.

















Reviews
There are no reviews yet.